Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eric Davis

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.
Journal of Cell Science|August 6, 2009
Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actinGreg P Coffey, Ranjani Rajapaksa, Raymond Liu, et al.
Blood Advances|August 19, 2024
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapiesNardjas Bettazova, Jana Senavova, Kristyna Kupcova, et al.
Molecular Cancer Research : MCR|February 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous LeukemiaSeemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Scientific Reports|February 23, 2012
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapyColleen M O'Connor, Sabina Sheppard, Cassie A Hartline, et al.
Leukemia|February 17, 2022
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALLSujan Piya, Yaling Yang, Seemana Bhattacharya, et al.
Nature Communications|February 17, 2019
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiationJun Yan, Qingnan Zhao, Konrad Gabrusiewicz, et al.
Oncotarget|November 16, 2017
Tumor <i>Trp53</i> status and genotype affect the bone marrow microenvironment in acute myeloid leukemiaRodrigo Jacamo, R Eric Davis, Xiaoyang Ling, et al.
Nature Communications|January 27, 2019
FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiationJun Yan, Qingnan Zhao, Konrad Gabrusiewicz, et al.
Blood|June 3, 2015
Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapyByung-Sik Cho, Zhihong Zeng, Hong Mu, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.
Journal of Cell Science|August 6, 2009
Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actinGreg P Coffey, Ranjani Rajapaksa, Raymond Liu, et al.
Blood Advances|August 19, 2024
Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapiesNardjas Bettazova, Jana Senavova, Kristyna Kupcova, et al.
Molecular Cancer Research : MCR|February 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous LeukemiaSeemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Scientific Reports|February 23, 2012
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapyColleen M O'Connor, Sabina Sheppard, Cassie A Hartline, et al.
Leukemia|February 17, 2022
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALLSujan Piya, Yaling Yang, Seemana Bhattacharya, et al.
Nature Communications|February 17, 2019
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiationJun Yan, Qingnan Zhao, Konrad Gabrusiewicz, et al.
Oncotarget|November 16, 2017
Tumor <i>Trp53</i> status and genotype affect the bone marrow microenvironment in acute myeloid leukemiaRodrigo Jacamo, R Eric Davis, Xiaoyang Ling, et al.
Nature Communications|January 27, 2019
FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiationJun Yan, Qingnan Zhao, Konrad Gabrusiewicz, et al.
Blood|June 3, 2015
Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapyByung-Sik Cho, Zhihong Zeng, Hong Mu, et al.
Pageof 9